BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4078313)

  • 1. Complement-dependent immune damage to liposomes containing gangliosides.
    Shichijo S; Toffano G; Alving CR
    J Immunol Methods; 1985 Dec; 85(1):53-63. PubMed ID: 4078313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response of rabbits to nerve ending gangliosides. Analysis of antibody specificity by liposome lysis and lysis inhibition assays.
    Uemura K; Kitazawa N; Taketomi T
    J Neuroimmunol; 1985 Sep; 9(5):269-80. PubMed ID: 4019749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of gangliosides on immune reactions of antibodies to neutral glycolipids in liposomes.
    Shichijo S; Alving CR
    Biochim Biophys Acta; 1986 Jun; 858(1):118-24. PubMed ID: 3707956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
    Perez CA; Ravindranath MH; Soh D; Gonzales A; Ye W; Morton DL
    Cancer J; 2002; 8(5):384-94. PubMed ID: 12416896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choleragen-mediated release of trapped glucose from liposomes containing ganglioside GM1.
    Moss J; Fishman PH; Richards RL; Alving CR; Vaughan M; Brady RO
    Proc Natl Acad Sci U S A; 1976 Oct; 73(10):3480-3. PubMed ID: 1068459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between natural and immunized anti-GM1 antibodies analyzed by marker releasing rate assay with liposome.
    Shichijo S; Tsunosue R; Ayabe M; Nakao M; Yokoyama MM
    Kurume Med J; 1992; 39(1):1-8. PubMed ID: 1619883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and properties of antibodies to GD3 and GM1 gangliosides.
    Kundu SK; Marcus DM; Veh RW
    J Neurochem; 1980 Jan; 34(1):184-8. PubMed ID: 6778957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential reactivities of fucosyl GM1 and GM1 gangliosides on rat erythrocyte membrane revealed by analysis with anti-fucosyl GM1 and GM1 antisera.
    Iwamori M; Shimomura J; Tsuyuhara S; Mogi M; Ishizaki S; Nagai Y
    J Biochem; 1983 Jul; 94(1):1-10. PubMed ID: 6619101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of influenza virus with gangliosides and liposomes containing gangliosides.
    Slepushkin VA; Starov AI; Bukrinskaya AG; Imbs AB; Martynova MA; Kogtev LS; Vodovozova EL; Timofeeva NG; Molotkovsky JG; Bergelson LD
    Eur J Biochem; 1988 May; 173(3):599-605. PubMed ID: 3371350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological specificity of the liposome lysis test for measurement of anti-ganglioside antibodies. A comparison with hemagglutination inhibition.
    Zemmour J; Portoukalian J; Doré JF
    J Immunol Methods; 1984 Feb; 66(2):331-40. PubMed ID: 6361155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
    Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
    Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dot-blot immunodetection of antibodies against GM1 and other gangliosides on PVDF-P membranes.
    Chabraoui F; Derrington EA; Mallie-Didier F; Confavreux C; Quincy C; Caudie C
    J Immunol Methods; 1993 Oct; 165(2):225-30. PubMed ID: 8228272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated bovine spinal motoneurons have specific ganglioside antigens recognized by sera from patients with motor neuron disease and motor neuropathy.
    Yoshino H; Miyatani N; Saito M; Ariga T; Lugaresi A; Latov N; Kushi Y; Kasama T; Yu RK
    J Neurochem; 1992 Nov; 59(5):1684-91. PubMed ID: 1383424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and characterization of gangliosides from Trypanosoma brucei.
    Uemura A; Watarai S; Kushi Y; Kasama T; Ohnishi Y; Kodama H
    J Parasitol; 2004 Feb; 90(1):123-7. PubMed ID: 15040678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of melanoma-associated gangliosides in cancer patients.
    Tai T; Cahan LD; Tsuchida T; Saxton RE; Irie RF; Morton DL
    Int J Cancer; 1985 May; 35(5):607-12. PubMed ID: 3997282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of choleragen and anti-ganglioside antibodies to gangliosides incorporated into preformed liposomes.
    Richards RL; Fishman PH; Moss J; Alving CR
    Biochim Biophys Acta; 1983 Sep; 733(2):249-55. PubMed ID: 6882761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of apparent neurological abnormalities in rabbits sensitized by gangliosides.
    Dasgupta S; Li D; Yu RK
    Neurochem Res; 2004 Nov; 29(11):2147-52. PubMed ID: 15662849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regenerative capacity of the goldfish visual system is affected by antibodies specific to gangliosides injected intraocularly.
    Spirman N; Sela BA; Gitler C; Calef E; Schwartz M
    J Neuroimmunol; 1984 Jun; 6(3):197-207. PubMed ID: 6725551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
    Nobile-Orazio E; Giannotta C; Briani C
    J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.